Cas 475108-35-1,N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluorophenyl}-N'-(1H-5-pyrazolyl)urea

475108-35-1

Post Buying Request

Basic information

Product Name: N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluorophenyl}-N'-(1H-5-pyrazolyl)urea
Synonyms: N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluorophenyl}-N'-(1H-5-pyrazolyl)urea
CAS NO:475108-35-1
Molecular Formula:
Molecular Weight: 423.403
EINECS: N/A
Product Categories: N/A
Mol File: 475108-35-1.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluorophenyl}-N'-(1H-5-pyrazolyl)urea(CAS DataBase Reference)
NIST Chemistry Reference: N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluorophenyl}-N'-(1H-5-pyrazolyl)urea(475108-35-1)
EPA Substance Registry System: N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluorophenyl}-N'-(1H-5-pyrazolyl)urea(475108-35-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 475108-35-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

475108-35-1 Suppliers

Recommended suppliersmore

475108-35-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 475108-35-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,5,1,0 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 475108-35:
(8*4)+(7*7)+(6*5)+(5*1)+(4*0)+(3*8)+(2*3)+(1*5)=151
151 % 10 = 1
So 475108-35-1 is a valid CAS Registry Number.

475108-35-1Upstream product

475108-35-1Downstream Products

475108-35-1Relevant articles and documents

Quinoline derivatives and quinazoline derivatives having azolyl group

-

, (2008/06/13)

An object of the present invention is to provide compounds having potent antitumor activity. The compounds according to the present invention are compounds represented by formula (I) or pharmaceutically acceptable salts or solvates thereof: wherein X and

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 475108-35-1